Ticker: DRIO

DarioHealth Corp. (NASDAQ: DRIO) - Q2 2025 executive snapshot What's happening: management is cutting operating costs and integrating acquisitions while leaning on a new Callodine credit facility ($32.5M drawn at close) to fund growth. Gross margins improved, but the company remains unprofitable,...